LLY - Eli Lilly and Company - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LLY is currently covered by 23 analysts with an average price target of $883.1. This is a potential upside of $106.66 (13.74%) from yesterday's end of day stock price of $776.44.

Eli Lilly and Company's activity chart (see below) currently has 488 price targets and 459 ratings on display. The stock rating distribution of LLY is 95.38% BUY and 4.62% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 85% with an average time for these price targets to be met of 246.24 days.

Highest price target for LLY is $1190, Lowest price target is $885, average price target is $969.95.

Most recent stock forecast was given by SEAMUS FERNANDEZ from GUGGENHEIM on 11-Jul-2025. First documented stock forecast 11-Nov-2013.

Currently out of the existing stock ratings of LLY, 124 are a BUY (95.38%), 6 are a HOLD (4.62%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$942

$170.29 (22.07%)

$936

11 days ago
(11-Jul-2025)

16/20 (80%)

$148.99 (18.79%)

539

Buy

$1135

$363.29 (47.08%)

$1124

12 days ago
(10-Jul-2025)

29/35 (82.86%)

$344.35 (43.55%)

176

Buy

$1100

$328.29 (42.54%)

$970

4 months 17 days ago
(05-Mar-2025)

13/16 (81.25%)

$170.28 (18.32%)

66

Buy

$1038

$266.29 (34.51%)

$1033

5 months 19 days ago
(03-Feb-2025)

1/4 (25%)

$228.96 (28.30%)

55

Buy

$1190

$418.29 (54.20%)

$1250

5 months 24 days ago
(28-Jan-2025)

0/3 (0%)

$386.39 (48.08%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LLY (Eli Lilly and Company) average time for price targets to be met?

On average it took 246.24 days on average for the stock forecasts to be realized with a an average price target met ratio 85

Which analyst has the current highest performing score on LLY (Eli Lilly and Company) with a proven track record?

AKASH TEWARI

Which analyst has the most public recommendations on LLY (Eli Lilly and Company)?

Akash Tewari works at JEFFERIES and has 6 price targets and 5 ratings on LLY

Which analyst is the currently most bullish on LLY (Eli Lilly and Company)?

Peter Verdult with highest potential upside - $418.29

Which analyst is the currently most reserved on LLY (Eli Lilly and Company)?

Marc Goodman with lowest potential downside - -$686.71

Eli Lilly and Company in the News

Analysis: 'Trump Effect' website takes credit for US investment made under Biden

By Jarrett Renshaw (Reuters) -Within hours of taking office in January, President Donald Trump boasted about attracting $3 trillion in new corporate investments to the United States. Since then, Trump has said the investments have swelled to $14 trillion, or roughly half of the nation’s annual gross domestic product. The White House calls it “The...

2 S&P 500 Dividend Stocks That Could Climb 17% or More, According to Wall Street

Key Points Stocks that pay dividends tend to outperform ones that don’t. Consensus price targets for Novo Nordisk suggest the stock can climb about 40% in the year ahead. Shares of Constellation Brands are way down, but Wall Street expects them to climb about 17% in the year ahead.10 stocks we like better than Novo...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?